The Osmotica product provides a controlled release tablet form of venlafaxine HCl including a previously unavailable 225 mg dosage strength. Equal doses of venlafaxine HCl Extended-release tablets are bioequivalent to Effexor XR capsules, a leading product marketed by Wyeth, when administered under fed conditions. Venlafaxine HCl Extended Release Tablets are not approved for use in paediatric patients. Venlafaxine HCl Extended-release Tablets may raise blood pressure in some patients. read more

Technorati Tags: venlafaxine, hcl, osmotica, tablets, extendedrelease, product, anxiety disorder news